BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

411 hedge funds and large institutions have $16.3B invested in BioMarin Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 158 increasing their positions, 148 reducing their positions, and 48 closing their positions.

Holders
411
Holders Change
-15
Holders Change %
-3.52%
% of All Funds
10.26%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.22%
New
40
Increased
158
Reduced
148
Closed
48
Calls
$97.7M
Puts
$79.3M
Net Calls
+$18.4M
Net Calls Change
+$31.5M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.94B
2
Citadel Advisors
2
Citadel Advisors
Florida
$153M
3
WRF
3
Waddell & Reed Financial
Kansas
$222M
4
Capital World Investors
4
Capital World Investors
California
$114M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$98.8M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$746M
2
Jennison Associates
2
Jennison Associates
New York
$1.15B
3
Wells Fargo
3
Wells Fargo
California
$62.4M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$0
5
YCMGA
5
York Capital Management Global Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.94B 20,850,601 +1,951,902 +10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.35B 14,550,680 +205,653 +1%
Jennison Associates
3
Jennison Associates
New York
$1.15B 12,314,357 -928,416 -7%
BlackRock
4
BlackRock
New York
$1.11B 11,882,561 +481,601 +4%
Primecap Management
5
Primecap Management
California
$897M 9,638,644 +328,420 +4%
Sands Capital Management
6
Sands Capital Management
Virginia
$750M 8,058,559 -446,922 -5%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$746M 8,019,391 -1,276,131 -14%
BBA
8
Baker Bros. Advisors
New York
$550M 5,905,673 – –
Invesco
9
Invesco
Georgia
$418M 4,489,391 +285,475 +7%
State Street
10
State Street
Massachusetts
$374M 4,014,268 +118,018 +3%
Temasek Holdings
11
Temasek Holdings
Singapore
$323M 3,472,712 – –
PAI
12
Palo Alto Investors
California
$227M 2,438,519 +53,800 +2%
WRF
13
Waddell & Reed Financial
Kansas
$222M 2,381,774 +1,241,693 +109%
Goldman Sachs
14
Goldman Sachs
New York
$220M 2,359,150 +395,081 +20%
Bank of America
15
Bank of America
North Carolina
$205M 2,207,554 +149,107 +7%
TCIM
16
TIAA CREF Investment Management
New York
$200M 2,146,708 -104,303 -5%
MNA
17
Manning & Napier Advisors
New York
$192M 2,065,710 -52,776 -2%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$187M 2,009,051 +368,486 +22%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$172M 1,844,893 -517,625 -22%
Citadel Advisors
20
Citadel Advisors
Florida
$153M 1,643,436 +1,401,415 +579%
Franklin Resources
21
Franklin Resources
California
$152M 1,630,004 -81,017 -5%
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$138M 1,480,724 -179,395 -11%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$133M 1,427,168 +24,328 +2%
Deutsche Bank
24
Deutsche Bank
Germany
$130M 1,392,080 +23,140 +2%
ClearBridge Investments
25
ClearBridge Investments
New York
$129M 1,390,890 +35,068 +3%
1
2 3 4 5